No Data
No Data
Investors in Exagen (NASDAQ:XGN) Have Unfortunately Lost 84% Over the Last Five Years
Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025
Strength Seen in Exagen (XGN): Can Its 29.4% Jump Turn Into More Strength?
Exagen Inc. to Participate in Upcoming Investor Conferences
Exagen Gains 28%, Insider Trades Reap Benefit
Express News | Cantor Fitzgerald Reiterates Overweight on Exagen, Maintains $8 Price Target